Clinical Trial Update: Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis. [Phase 2]

View source ↗

Summary

A Phase 2 trial of POL7080 in exacerbations of non-cystic fibrosis bronchiectasis was terminated; the update notes evaluation of safety, efficacy and PK/PD prio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis
• Lower Respiratory Tract Infection

Drugs mentioned

• POL7080

Snippet

Sponsor: Polyphor Ltd. | Conditions: Bronchiectasis, Lower Respiratory Infection | Phase 2 | Status: TERMINATED